-
Study aim
-
The comparison of Platelet-rich plasma (PRF) and Concentrated growth factor (CGF) in the treatment of immediate implant of teeth with the periapical lesion.
-
Design
-
Clinical Trial with the control group, with parallel groups, randomized, 2-3rd phase on 27 patients. The randomization tool is the random number table.
-
Settings and conduct
-
Patients referring to the dentistry faculty of Guilan are chosen if matched with inclusion criteria; divided into 3 groups and related intervention according to the group will be performed. This study is not blinded.
-
Participants/Inclusion and exclusion criteria
-
Healthy patient in terms of systemic diseases, with remaining roots, soft tissue, and buccal bone plate in a normal distance from the CEJ, plaque index less than 25%, and teeth with periapical lesion was included in the study. Smoking, pregnancy, history of radiotherapy and chemotherapy, active infection, type 2 and 3 sockets, advanced periodontitis and marginal bone recession, blood disease and diabetes, periapical lesion larger than 7 millimeters and Bruxism lead to exclusion of the patient from the study
-
Intervention groups
-
After the extraction of the tooth with a periapical lesion, in the control group, the immediate implant is placed; in the first intervention group Platelet-rich plasma with the immediate implant, and in the second intervention group Concentrated growth factor with the immediate implant is placed.
-
Main outcome variables
-
Pain is recorded using VAS 1, 6, 24, and 48 hours post-surgery.
At baseline, 1st, 3rd, and 6th-month post-surgery following indices are measure: Healing of soft tissue using EHI; Esthetic of gingiva at mid buccal, mesial, and distal of the implant as 0 to 4; Plaque index and Bleeding index as a percent.
At baseline, 3rd, and 6th-month post-surgery, using a radiography healing of the lesion and crestal bone level are measured. After 6 months, IHS is reported